The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
A Highly Significant Association between a COMT Haplotype and Schizophrenia
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Future of Genetic Studies of Complex Human Diseases
Risch, N., & Merikangas, K. (1996) · Science · doi:10.1126/science.273.5281.1516 · Cited by 5,355
Self-citationEffect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D., & Weinberger, D. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111134598 · Cited by 2,381
Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y.-M., Szumlanski, C. L., & Weinshilboum, R. M. (1996) · Pharmacogenetics · doi:10.1097/00008571-199606000-00007 · Cited by 1,788 · cited 1×
“A nonsynonymous SNP at codon 108/158 in the COMT gene generates a valine-to-methionine (Val/Met) substitution and apparently influences the enzyme’s activity (Lachman et al. 1996).”
BackgroundEnzymatic O-methylation of epinephrine and other catechols
Axelrod, J., & Tomchick, R. (1958) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64731-3 · Cited by 1,283 · cited 1×
“COMT is one of the enzymes that degrade catecholamines, including dopamine (Axelrod and Tomchick 1958).”
BackgroundA Comparison of Linkage Disequilibrium Measures for Fine-Scale Mapping
DEVLIN, B., & RISCH, N. (1995) · Genomics · doi:10.1006/geno.1995.9003 · Cited by 1,044
Self-citationHigh rates of schizophrenia in adults with velo-cardio-facial syndrome
Murphy, K. C., Jones, L. A., & Owen, M. J. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.10.940 · Cited by 1,024
Gogos, J. A., Morgan, M., Luine, V., Santha, M., Ogawa, S., Pfaff, D., & Karayiorgou, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9991 · Cited by 864
Prefrontal neurons and the genetics of schizophrenia
Weinberger, D. R., Egan, M. F., Bertolino, A., Callicott, J. H., Mattay, V. S., Lipska, B. K., Berman, K. F., & Goldberg, T. E. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01252-5 · Cited by 741
Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11.
Karayiorgou, M., Morris, M. A., Morrow, B., Shprintzen, R. J., Goldberg, R., Borrow, J., Gos, A., Nestadt, G., Wolyniec, P. S., & Lasseter, V. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7612 · Cited by 628
Testing for linkage disequilibrium in genotypic data using the Expectation-Maximization algorithm
Slatkin, M., & Excoffier, L. (1996) · Heredity · doi:10.1038/hdy.1996.55 · Cited by 573
Cited by
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Burnside, R. D. (2015) · Cytogenetic and Genome Research · doi:10.1159/000438708 · Cited by 1,946
Chen, J., Lipska, B. K., Halim, N., Ma, Q. D., Matsumoto, M., Melhem, S., Kolachana, B. S., Hyde, T. M., Herman, M. M., Apud, J., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/425589 · Cited by 1,675
Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.026 · Cited by 1,409
Diatchenko, L., Slade, G. D., Nackley, A. G., Bhalang, K., Sigurdsson, A., Belfer, I., Goldman, D., Xu, K., Shabalina, S. A., Shagin, D., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi013 · Cited by 1,280
Intermediate phenotypes and genetic mechanisms of psychiatric disorders
Meyer-Lindenberg, A., & Weinberger, D. R. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1993 · Cited by 1,216
The genetics of addictions: uncovering the genes
Goldman, D., Oroszi, G., & Ducci, F. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1635 · Cited by 1,099
Neurobiology of Aggression and Violence
Siever, L. J. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07111774 · Cited by 984
“Differences in allele frequency of a single nucleotide polymorphism, rs165599, in the catecholamine-O-methyltransferase gene (121) have been associated with increased physical aggression and aggressive responses on the Point Subtraction Aggression Paradigm in patients with personality disorders (122).”
BackgroundBilder, R. M., Volavka, J., Lachman, H. M., & Grace, A. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300542 · Cited by 769
Catechol-o-Methyltransferase, Cognition, and Psychosis: Val158Met and Beyond
Tunbridge, E. M., Harrison, P. J., & Weinberger, D. R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.024 · Cited by 685
Genes for schizophrenia? Recent findings and their pathophysiological implications
Harrison, P. J., & Owen, M. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12379-3 · Cited by 597
The genetics of schizophrenia and bipolar disorder: dissecting psychosis
Craddock, N., O’Donovan, M. C., & Owen, M. J. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.030718 · Cited by 574
Murray, R. M., Sham, P., Van Os, J., Zanelli, J., Cannon, M., & McDonald, C. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.03.002 · Cited by 516
Genes for Schizophrenia and Bipolar Disorder? Implications for Psychiatric Nosology
Craddock, N. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj033 · Cited by 496
Tunbridge, E. M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1124-04.2004 · Cited by 418
Ayalew, M., Le-Niculescu, H., Levey, D. F., Jain, N., Changala, B., Patel, S. D., Winiger, E., Breier, A., Shekhar, A., Amdur, R., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.37 · Cited by 397
Fallin, M. D., Lasseter, V. K., Avramopoulos, D., Nicodemus, K. K., Wolyniec, P. S., McGrath, J. A., Steel, G., Nestadt, G., Liang, K.-Y., Huganir, R. L., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/497703 · Cited by 395
Catechol- O -methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli
Diatchenko, L., Nackley, A. G., Slade, G. D., Bhalang, K., Belfer, I., Max, M. B., Goldman, D., & Maixner, W. (2006) · Pain · doi:10.1016/j.pain.2006.05.024 · Cited by 372
Salanti, G., Amountza, G., Ntzani, E. E., & Ioannidis, J. P. A. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201410 · Cited by 371
Genomewide association for schizophrenia in the CATIE study: results of stage 1
Sullivan, P. F., Lin, D., Tzeng, J.-Y., van den Oord, E., Perkins, D., Stroup, T. S., Wagner, M., Lee, S., Wright, F. A., Zou, F., et al. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.25 · Cited by 355
Shifman, S., Johannesson, M., Bronstein, M., Chen, S. X., Collier, D. A., Craddock, N. J., Kendler, K. S., Li, T., O'Donovan, M., O'Neill, F. A., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.0040028 · Cited by 345
Self-citationBray, N. J., Buckland, P. R., Williams, N. M., Williams, H. J., Norton, N., Owen, M. J., & O’Donovan, M. C. (2003) · The American Journal of Human Genetics · doi:10.1086/376578 · Cited by 335
Sullivan, P. F. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020212 · Cited by 321
The molecular genetics of schizophrenia: new findings promise new insights
Owen, M. J., Williams, N. M., & O'Donovan, M. C. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001444 · Cited by 321
COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome
Gothelf, D., Eliez, S., Thompson, T., Hinard, C., Penniman, L., Feinstein, C., Kwon, H., Jin, S., Jo, B., Antonarakis, S. E., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1572 · Cited by 319
Impact of complex genetic variation in COMT on human brain function
Meyer-Lindenberg, A., Nichols, T., Callicott, J. H., Ding, J., Kolachana, B., Buckholtz, J., Mattay, V. S., Egan, M., & Weinberger, D. R. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001860 · Cited by 319
Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia
Mukai, J., Liu, H., Burt, R. A., Swor, D. E., Lai, W.-S., Karayiorgou, M., & Gogos, J. A. (2004) · Nature Genetics · doi:10.1038/ng1375 · Cited by 315
Harrison, P. J., & Tunbridge, E. M. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301543 · Cited by 308
Bertolino, A., Caforio, G., Blasi, G., De Candia, M., Latorre, V., Petruzzella, V., Altamura, M., Nappi, G., Papa, S., Callicott, J. H., et al. (2004) · American Journal of Psychiatry · doi:10.1176/ajp.161.10.1798 · Cited by 289
Neurobehavioral evidence for changes in dopamine system activity during adolescence
Wahlstrom, D., White, T., & Luciana, M. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.12.007 · Cited by 277
“as well as psychiatric disorders such as ADHD, schizophrenia, and alcoholism (Brookes et al., 2006; Shifman et al., 2002).”
BackgroundStraub, R. E., Lipska, B. K., Egan, M. F., Goldberg, T. E., Callicott, J. H., Mayhew, M. B., Vakkalanka, R. K., Kolachana, B. S., Kleinman, J. E., & Weinberger, D. R. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001988 · Cited by 276
Barnett, J. H., Jones, P. B., Robbins, T. W., & Müller, U. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001973 · Cited by 274
Personalized medicine in psychiatry: problems and promises
Ozomaro, U., Wahlestedt, C., & Nemeroff, C. B. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-132 · Cited by 270
Subtyping schizophrenia: implications for genetic research
Jablensky, A. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001857 · Cited by 268
Paterlini, M., Zakharenko, S. S., Lai, W.-S., Qin, J., Zhang, H., Mukai, J., Westphal, K. G. C., Olivier, B., Sulzer, D., Pavlidis, P., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1562 · Cited by 265
Hattori, E., Liu, C., Badner, J. A., Bonner, T. I., Christian, S. L., Maheshwari, M., Detera-Wadleigh, S. D., Gibbs, R. A., & Gershon, E. S. (2003) · The American Journal of Human Genetics · doi:10.1086/374822 · Cited by 263
Phenotype of schizophrenia: a review and formulation
Tamminga, C. A., & Holcomb, H. H. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001563 · Cited by 262
Fan, J.-B., Zhang, C.-S., Gu, N.-F., Li, X.-W., Sun, W.-W., Wang, H.-Y., Feng, G.-Y., St. Clair, D., & He, L. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.018 · Cited by 259
Munafò, M. R., Bowes, L., Clark, T. G., & Flint, J. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001664 · Cited by 259
The kynurenine pathway in schizophrenia and bipolar disorder
Erhardt, S., Schwieler, L., Imbeault, S., & Engberg, G. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.05.020 · Cited by 255
Genes, cognition and brain through a COMT lens
Dickinson, D., & Elvevåg, B. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.014 · Cited by 253
Craddock, N., Owen, M. J., & O'Donovan, M. C. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001808 · Cited by 216
Tunbridge, E., Weickert, C., Kleinman, J., Herman, M., Chen, J., Kolachana, B., Harrison, P., & Weinberger, D. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhl032 · Cited by 197
Molecular genetic studies of schizophrenia
Riley, B., & Kendler, K. S. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201571 · Cited by 190
Dopamine and psychosis: Theory, pathomechanisms and intermediate phenotypes
Tost, H., Alam, T., & Meyer-Lindenberg, A. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.06.005 · Cited by 160
Schizophrenia and bipolar disorder: differences and overlaps
Maier, W., Zobel, A., & Wagner, M. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000214342.52249.82 · Cited by 156
Singleton deletions throughout the genome increase risk of bipolar disorder
Zhang, D., Cheng, L., Qian, Y., Alliey-Rodriguez, N., Kelsoe, J. R., Greenwood, T., Nievergelt, C., Barrett, T. B., McKinney, R., Schork, N., et al. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.144 · Cited by 148
Stefanis, N. C., Os, J. V., Avramopoulos, D., Smyrnis, N., Evdokimidis, I., Hantoumi, I., & Stefanis, C. N. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.038 · Cited by 138
Barnett, J. H., Heron, J., Ring, S. M., Golding, J., Goldman, D., Xu, K., & Jones, P. B. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.1.142 · Cited by 134
Dempster, E. L., Mill, J., Craig, I. W., & Collier, D. A. (2006) · BMC Medical Genetics · doi:10.1186/1471-2350-7-10 · Cited by 129
Impact of interacting functional variants in COMT on regional gray matter volume in human brain
Honea, R., Verchinski, B. A., Pezawas, L., Kolachana, B. S., Callicott, J. H., Mattay, V. S., Weinberger, D. R., & Meyer-Lindenberg, A. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.10.064 · Cited by 128
Budel, S., Padukkavidana, T., Liu, B. P., Feng, Z., Hu, F., Johnson, S., Lauren, J., Park, J. H., McGee, A. W., Liao, J., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3828-08.2008 · Cited by 107
Carlson, G. C., Talbot, K., Halene, T. B., Gandal, M. J., Kazi, H. A., Schlosser, L., Phung, Q. H., Gur, R. E., Arnold, S. E., & Siegel, S. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109625108 · Cited by 103
Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome
Monks, S., Niarchou, M., Davies, A. R., Walters, J. T. R., Williams, N., Owen, M. J., van den Bree, M. B. M., & Murphy, K. C. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.01.020 · Cited by 93
Rodríguez-Santiago, B., Brunet, A., Sobrino, B., Serra-Juhé, C., Flores, R., Armengol, L., Vilella, E., Gabau, E., Guitart, M., Guillamat, R., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.53 · Cited by 88
Subtle gene-environment interactions driving paranoia in daily life
Simons, C. J. P., Wichers, M., Derom, C., Thiery, E., Myin‐Germeys, I., Krabbendam, L., & Van Os, J. (2009) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2008.00434.x · Cited by 82
Wichers, M., Aguilera, M., Kenis, G., Krabbendam, L., Myin-Germeys, I., Jacobs, N., Peeters, F., Derom, C., Vlietinck, R., Mengelers, R., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301520 · Cited by 78
Smyrnis, N., Avramopoulos, D., Evdokimidis, I., Stefanis, C. N., Tsekou, H., & Stefanis, N. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.019 · Cited by 72
Michaelovsky, E., Gothelf, D., Korostishevsky, M., Frisch, A., Burg, M., Carmel, M., Steinberg, T., Inbar, D., Apter, A., & Weizman, A. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008085 · Cited by 53
Self-citation22q11 deletion syndrome: a review of the neuropsychiatric features and their neurobiological basis
Squarcione, C., Torti, M. C., Di Fabio, F., & Biondi, M. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s52188 · Cited by 46
Effects of Comt Genotype on Behavioral Symptomatology in the 22q11.2 Deletion Syndrome
Bearden, C. E., Jawad, A. F., Lynch, D. R., Monterossso, J. R., Sokol, S., McDonald-McGinn, D. M., Saitta, S. C., Harris, S. E., Moss, E., Wang, P. P., et al. (2005) · Child Neuropsychology · doi:10.1080/09297040590911239 · Cited by 42
Genetics and neuroimaging of attention and hypnotizability may elucidate placebo
Raz, A. (2007) · International Journal of Clinical and Experimental Hypnosis · doi:10.1080/00207140701506482 · Cited by 25
Metadata
- Authors
- Shifman, S., Bronstein, M., Sternfeld, M., Pisanté-Shalom, A., Lev-Lehman, E., Weizman, A., Reznik, I., Spivak, B., Grisaru, N., Karp, L., Schiffer, R., Kotler, M., Strous, R. D., Swartz-Vanetik, M., Knobler, H. Y., Shinar, E., Beckmann, J. S., Yakir, B., Risch, N., Zak, N. B., & Darvasi, A.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2002-12
- Volume
- 71
- Issue
- 6
- Pages
- 1296-1302
- ISSN
- 0002-9297 (ISSN-L)
- OpenAlex
- W2138222426
- Cited by
- 691
- References
- 34
- FWCI
- 31.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.